July 28, 2025

Oxford Finance Appoints Nick McDearis to Lead ABL Originations, Expands into Traditional ABL Market

News | Healthcare | Real Estate & ABL

July 21, 2025

Oxford Finance Surpasses $600 Million in Leveraged Lending Capital Deployment in First Half of 2025

News | Healthcare | Leveraged Lending

July 15, 2025

Oxford Finance’s Real Estate and ABL Team Achieves Over $715 Million in New Loan Volume in First Half of 2025

News | Healthcare | Real Estate & ABL

April 16, 2025

Oxford Finance Completes Strong First Quarter With Leveraged Lending Capital Deployment Exceeding $400 Million

News | Healthcare | Leveraged Lending

March 12, 2025

Oxford Finance LLC Announces Management Succession

News

January 13, 2025

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance

News | Enterprise Lending | Life Sciences

January 13, 2025

Oxford Finance Closes Fourth Consecutive Year with New Leveraged Lending Commitments Exceeding $1 Billion

News | Healthcare | Leveraged Lending

December 18, 2024

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC

News | Enterprise Lending | Life Sciences

November 7, 2024

Orthofix Announces New Term Loan

News | Enterprise Lending | Life Sciences

August 12, 2024

Oxford Finance’s Leveraged Lending Team Provides 2024 Year-To-Date Update 

News | Healthcare | Leveraged Lending

August 12, 2024

Oxford Finance Provides $47 Million Credit Facility to Creative Solutions in Healthcare, Inc.

News | Healthcare | Real Estate & ABL

July 16, 2024

Oxford Finance Appoints David Hickman and Garrett Henn as Co-Heads of Enterprise Lending

News | Enterprise Lending | Life Sciences